For more information about this case, please contactSherrie R. Savett, Esq. Carole A. Broderick, Esq. Douglas R. Risen, Esq.BERGER & MONTAGUE, P.C.1622 Locust Street Philadelphia, PA 19103888-891-2289 email@example.com www.bergermontague.com Berger & Montague, P.C. has extensive experience in securities litigation involving securities law violations regarding drugs and matters concerning Food and Drug Administration law and regulations, including a successful action for violation of the federal securities laws against ViroPharma concerning a drug under development that purportedly reduced the duration of the common cold, which was abandoned by the Company. Berger & Montague has also successfully litigated actions for violations of the securities laws against Nuvelo, Inc., Hemispherix Biopharma, CryoLife, Inc., Cephalon, Inc., Genentech, Inc., Sepracor, Inc., U.S. Bioscience, Synergen, Inc., Cryomedical Sciences, MediImmune, Inc., and Andrx Corp. The firm was founded in 1970, is a pioneer in class action litigation. The firm's 70 attorneys concentrate their practice in complex litigation, including securities fraud, whistleblower and false claims actions and have recovered several billion dollars for consumers and investors. SOURCE Berger & Montague, P.C.